An innovative collaboration is tying together the expertise and curiosity of Mayo Clinic autoimmune neurology researchers with eager patients who have a rare disease and are looking for answers.

The nonprofit patient advocacy group called The MOG Project supports patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), which is a rare and debilitating central nervous system demyelinating disorder. A team of Mayo Clinic neurologists, neuro-ophthalmologists, and the Autoimmune Neurology Laboratory at Mayo Clinic share a unique relationship with The MOG Project as they harness the power of patients’ experiences with MOGAD and their biospecimen data to advance the science behind this disease.

This collaboration benefits both patients affected by MOGAD and scientists on the front lines of discovery.

Read more in this Eye on Innovation story on Mayo Clinic Laboratories Insights.